Varinder Athwal

1.1k total citations
35 papers, 785 citations indexed

About

Varinder Athwal is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Varinder Athwal has authored 35 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 15 papers in Epidemiology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Varinder Athwal's work include Liver Disease Diagnosis and Treatment (14 papers), Liver physiology and pathology (8 papers) and Cystic Fibrosis Research Advances (7 papers). Varinder Athwal is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Liver physiology and pathology (8 papers) and Cystic Fibrosis Research Advances (7 papers). Varinder Athwal collaborates with scholars based in United Kingdom, United States and Australia. Varinder Athwal's co-authors include Karen Piper Hanley, Neil A. Hanley, James Pritchett, Katherine J. Martin, Scott L. Friedman, Neil Roberts, Emma Harvey, Aoibheann Mullan, Jessica Llewellyn and Leo Zeef and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Varinder Athwal

32 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Varinder Athwal United Kingdom 13 254 251 224 156 135 35 785
Sacha Robert France 8 226 0.9× 256 1.0× 159 0.7× 47 0.3× 96 0.7× 12 652
Lidia Tihaa Germany 12 322 1.3× 224 0.9× 217 1.0× 48 0.3× 99 0.7× 14 695
Rose Christian United States 5 420 1.7× 499 2.0× 205 0.9× 116 0.7× 123 0.9× 6 964
Jonas Feilchenfeldt Switzerland 12 389 1.5× 87 0.3× 112 0.5× 119 0.8× 88 0.7× 14 868
Kenji Sakakibara Japan 17 257 1.0× 200 0.8× 166 0.7× 39 0.3× 101 0.7× 51 771
Nadja Lehwald Germany 14 300 1.2× 213 0.8× 156 0.7× 36 0.2× 291 2.2× 45 922
Laura Hargrove United States 18 192 0.8× 271 1.1× 252 1.1× 40 0.3× 246 1.8× 30 798
Wei Qiu China 17 222 0.9× 250 1.0× 67 0.3× 43 0.3× 85 0.6× 54 717
Jiqi Yan China 15 263 1.0× 162 0.6× 178 0.8× 35 0.2× 302 2.2× 41 775
Përparim Limani Switzerland 18 204 0.8× 247 1.0× 292 1.3× 44 0.3× 370 2.7× 41 893

Countries citing papers authored by Varinder Athwal

Since Specialization
Citations

This map shows the geographic impact of Varinder Athwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Varinder Athwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Varinder Athwal more than expected).

Fields of papers citing papers by Varinder Athwal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Varinder Athwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Varinder Athwal. The network helps show where Varinder Athwal may publish in the future.

Co-authorship network of co-authors of Varinder Athwal

This figure shows the co-authorship network connecting the top 25 collaborators of Varinder Athwal. A scholar is included among the top collaborators of Varinder Athwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Varinder Athwal. Varinder Athwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allen, Alex, Martin Prince, Susana Rodrigues, et al.. (2025). Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review. PubMed. 3(1). 13–13. 1 indexed citations
2.
Athwal, Varinder, et al.. (2024). Investigation of abnormal liver blood tests in patients with inflammatory bowel disease. Frontline Gastroenterology. 15(6). 516–522.
3.
4.
Llewellyn, Jessica, James Pritchett, Leo Zeef, et al.. (2023). Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease. Cells. 12(12). 1582–1582. 8 indexed citations
5.
Scott, Jennifer A., Andrew Jones, Timothy T. Gordon‐Walker, et al.. (2023). Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools. Heliyon. 9(11). e21861–e21861. 5 indexed citations
6.
Tewkesbury, Daniel, Varinder Athwal, R.J. Bright-Thomas, Andrew Jones, & Peter Barry. (2023). Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on liver tests at a large single adult cystic fibrosis centre. Journal of Cystic Fibrosis. 22(2). 256–262. 33 indexed citations
7.
Mullan, Aoibheann, Katherine J. Martin, James Pritchett, et al.. (2023). PAK1-dependent mechanotransduction enables myofibroblast nuclear adaptation and chromatin organization during fibrosis. Cell Reports. 42(11). 113414–113414. 9 indexed citations
8.
Scott, Jennifer A., Andrew Jones, Karen Piper Hanley, & Varinder Athwal. (2022). Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis. Alimentary Pharmacology & Therapeutics. 55(4). 389–400. 10 indexed citations
9.
Athwal, Varinder, et al.. (2022). Kidney Transplantation From Hepatitis-C Viraemic Donors:Considerations for Practice in the United Kingdom. Transplant International. 35. 10277–10277. 2 indexed citations
10.
El‐Khateeb, Eman, Adam S. Darwich, Brahim Achour, Varinder Athwal, & Amin Rostami‐Hodjegan. (2021). Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment. Alimentary Pharmacology & Therapeutics. 54(4). 388–401. 38 indexed citations
11.
Pritchett, James, Katherine J. Martin, Aoibheann Mullan, et al.. (2021). SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function. Science Signaling. 14(672). 29 indexed citations
12.
Whorwell, Peter J., et al.. (2021). Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?. World Journal of Hepatology. 13(12). 1816–1827. 12 indexed citations
13.
Martin, Katherine J., et al.. (2021). Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications. Current Diabetes Reports. 21(3). 8–8. 33 indexed citations
14.
El‐Khateeb, Eman, Brahim Achour, Daniel Scotcher, et al.. (2020). Scaling Factors for Clearance in Adult Liver Cirrhosis. Drug Metabolism and Disposition. 48(12). 1271–1282. 19 indexed citations
15.
Scott, Jennifer A., Peter Barry, Andrew Jones, & Varinder Athwal. (2020). Management of superior mesenteric venous thrombus in cystic fibrosis related liver disease. Paediatric Respiratory Reviews. 35. 106–108.
16.
Athwal, Varinder, James Pritchett, Katherine J. Martin, et al.. (2018). SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis. Scientific Reports. 8(1). 17905–17905. 37 indexed citations
17.
Scott, Jennifer A., et al.. (2018). Secondary sclerosing cholangitis following extracorporeal membrane oxygenation for acute respiratory distress in polytrauma. Clinical Case Reports. 6(9). 1849–1853. 7 indexed citations
18.
Martin, Katherine J., James Pritchett, Jessica Llewellyn, et al.. (2016). PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis. Nature Communications. 7(1). 12502–12502. 167 indexed citations
19.
Kim, Rosa S., Daisuke Hasegawa, Nicolas Goossens, et al.. (2016). The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy. Scientific Reports. 6(1). 39342–39342. 74 indexed citations
20.
Pritchett, James, Varinder Athwal, Emma Harvey, et al.. (2014). Epimorphin Alters the Inhibitory Effects of SOX9 on Mmp13 in Activated Hepatic Stellate Cells. PLoS ONE. 9(6). e100091–e100091. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sacha Robert Breakdown of academic impact, for papers by Lidia Tihaa Breakdown of academic impact, for papers by Rose Christian Breakdown of academic impact, for papers by Jonas Feilchenfeldt Breakdown of academic impact, for papers by Kenji Sakakibara Breakdown of academic impact, for papers by Nadja Lehwald Breakdown of academic impact, for papers by Laura Hargrove Breakdown of academic impact, for papers by Wei Qiu Breakdown of academic impact, for papers by Jiqi Yan Breakdown of academic impact, for papers by Përparim Limani
Rankless by CCL
2026